002107 沃华医药
已收盘 03-05 15:00:00
资讯
新帖
简况
沃华医药(002107)披露2025年度权益分派实施公告,2月26日股价下跌1.51%
证券之星 · 02-26
沃华医药(002107)披露2025年度权益分派实施公告,2月26日股价下跌1.51%
沃华医药(002107)披露2025年度业绩网上说明会安排,1月28日股价下跌1.32%
证券之星 · 01-28
沃华医药(002107)披露2025年度业绩网上说明会安排,1月28日股价下跌1.32%
股市必读:沃华医药(002107)1月20日收盘跌6.01%,主力净流出143.94万元
证券之星 · 01-21
股市必读:沃华医药(002107)1月20日收盘跌6.01%,主力净流出143.94万元
沃华医药:拟向全体股东每10股派发现金红利1.46元(含税)
新京报 · 01-19
沃华医药:拟向全体股东每10股派发现金红利1.46元(含税)
沃华医药最新公告:2025年净利润同比增长162.93%
证券之星 · 01-19
沃华医药最新公告:2025年净利润同比增长162.93%
沃华医药最新公告:2025年净利同比预增119.76%-215.90%
证券之星 · 01-13
沃华医药最新公告:2025年净利同比预增119.76%-215.90%
沃华医药:不存在可能触发退市风险警示的情形
证券之星 · 2025-12-23
沃华医药:不存在可能触发退市风险警示的情形
异动快报:沃华医药(002107)12月4日9点31分触及涨停板
证券之星 · 2025-12-04
异动快报:沃华医药(002107)12月4日9点31分触及涨停板
沃华医药(002107)披露变更会计师事务所议案获股东会通过,11月28日股价下跌1.11%
证券之星 · 2025-11-28
沃华医药(002107)披露变更会计师事务所议案获股东会通过,11月28日股价下跌1.11%
天价离婚撕开A股公司治理隐忧:沃华医药“无主”之后路在何方?
新浪证券 · 2025-11-14
天价离婚撕开A股公司治理隐忧:沃华医药“无主”之后路在何方?
沃华医药(002107)披露召开2025年第四次临时股东会通知,11月12日股价上涨0.94%
证券之星 · 2025-11-12
沃华医药(002107)披露召开2025年第四次临时股东会通知,11月12日股价上涨0.94%
沃华医药(002107)披露公司实际控制人变动,11月04日股价下跌0.32%
证券之星 · 2025-11-04
沃华医药(002107)披露公司实际控制人变动,11月04日股价下跌0.32%
判了!离婚财产分割,沃华医药变更为无实控人!
e公司 · 2025-11-04
判了!离婚财产分割,沃华医药变更为无实控人!
沃华医药(002107.SZ)将变为无实控人状态
智通财经 · 2025-11-04
沃华医药(002107.SZ)将变为无实控人状态
沃华医药(002107)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
证券之星 · 2025-10-19
沃华医药(002107)2025年三季报简析:营收净利润同比双双增长,盈利能力上升
沃华医药最新公告:前三季度净利润同比增长179.34%
证券之星 · 2025-10-17
沃华医药最新公告:前三季度净利润同比增长179.34%
沃华医药:9月5日高管张戈减持股份合计251.46万股
证券之星 · 2025-09-08
沃华医药:9月5日高管张戈减持股份合计251.46万股
沃华医药最新公告:选举印文军为公司监事长
证券之星 · 2025-02-10
沃华医药最新公告:选举印文军为公司监事长
沃华医药(002107)1月14日主力资金净买入272.27万元
证券之星 · 2025-01-14
沃华医药(002107)1月14日主力资金净买入272.27万元
加载更多
公司概况
公司名称:
山东沃华医药科技股份有限公司
所属行业:
医药制造业
上市日期:
2007-01-24
主营业务:
山东沃华医药科技股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是心脑血管系统类药物、风湿骨病/跌打损伤类药物、肝胆/结石类药物、感冒发热类药物、止咳平喘类药物、胃肠疾病类药物、补益类药物、妇科药物、抗感染类药物、清热解毒/泻火通便类药物、五官科药物、皮肤科药物、维生素/矿物质/营养补充类药物、阿尔兹海默症药物、其他专科/辅助用药类药物。曾荣获国家中药标准化项目、国家重大新药创制、中华民族医药学会科学技术奖一等奖,863计划、国家重大新药创制专项、国家科学技术进步二等奖、山东省科技重大专项、山东省科技技术进步二等奖、中国制药品牌榜新锐品牌、百姓放心药等。
发行价格:
10.85
{"stockData":{"symbol":"002107","market":"SZ","secType":"STK","nameCN":"沃华医药","latestPrice":6.72,"timestamp":1772694201000,"preClose":6.71,"halted":0,"volume":7372488,"delay":0,"changeRate":0.0015,"floatShares":571000000,"shares":577000000,"eps":0.2686,"marketStatus":"已收盘","change":0.01,"latestTime":"03-05 15:00:00","open":6.78,"high":6.81,"low":6.68,"amount":49667200,"amplitude":0.0194,"askPrice":6.72,"askSize":1009,"bidPrice":6.71,"bidSize":197,"shortable":0,"etf":0,"ttmEps":0.2686,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772760600000},"marketStatusCode":5,"adr":0,"adjPreClose":6.71,"symbolType":"stock","openAndCloseTimeList":[[1772674200000,1772681400000],[1772686800000,1772694000000]],"highLimit":7.38,"lowLimit":6.04,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":577209600,"isCdr":false,"pbRate":5.47,"roa":"--","peRate":25.018615,"roe":"13.15%","epsLYR":0.17,"committee":-0.292802,"marketValue":3879000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":3840000000},"requestUrl":"/m/hq/s/002107","defaultTab":"news","newsList":[{"id":"2614502548","title":"沃华医药(002107)披露2025年度权益分派实施公告,2月26日股价下跌1.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614502548","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614502548?lang=zh_cn&edition=full","pubTime":"2026-02-26 23:18","pubTimestamp":1772119098,"startTime":"0","endTime":"0","summary":"截至2026年2月26日收盘,沃华医药报收于7.18元,较前一交易日下跌1.51%,最新总市值为41.44亿元。该股当日开盘7.28元,最高7.28元,最低7.16元,成交额达5491.67万元,换手率为1.33%。近日,沃华医药发布《2025年度权益分派实施公告》。公告显示,公司2025年度权益分派方案已获2026年2月9日召开的股东会审议通过。本次权益分派股权登记日为2026年3月4日,除息日为2026年3月5日。A股股东现金红利由证券公司直接划入资金账户,部分股东由公司自行派发。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600037833.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2606103957","title":"沃华医药(002107)披露2025年度业绩网上说明会安排,1月28日股价下跌1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606103957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606103957?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:41","pubTimestamp":1769611274,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘,沃华医药报收于7.45元,较前一交易日下跌1.32%,最新总市值为43亿元。该股当日开盘7.55元,最高7.61元,最低7.41元,成交额达7278.4万元,换手率为1.7%。近日,沃华医药发布《关于召开网上业绩说明会的通知》。公告显示,公司已于2026年1月20日在巨潮资讯网披露了《2025年度报告》及其摘要。为便于投资者了解公司生产经营情况,公司将于2026年2月5日15:00–17:00举行2025年度业绩网上说明会,通过中证路演中心进行网络远程交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800043109.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2605110751","title":"股市必读:沃华医药(002107)1月20日收盘跌6.01%,主力净流出143.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110751","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605110751?lang=zh_cn&edition=full","pubTime":"2026-01-21 00:59","pubTimestamp":1768928347,"startTime":"0","endTime":"0","summary":"截至2026年1月20日收盘,沃华医药报收于7.2元,下跌6.01%,换手率6.39%,成交量36.5万手,成交额2.67亿元。交易信息汇总1月20日沃华医药收盘报7.2元,跌6.01%,当日成交3650.47万元。股本股东变化股东户数变动截至2025年12月31日,沃华医药股东户数为4.01万户,较9月30日减少937户,减幅2.29%。2025年度董事会工作报告2025年公司实现营业收入81,695.24万元,同比增长6.96%;归母净利润9,571.53万元,同比增长162.93%。2025年度实际发生金额为513.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100000441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0},{"id":"2604318971","title":"沃华医药:拟向全体股东每10股派发现金红利1.46元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604318971","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604318971?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:27","pubTimestamp":1768832820,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 1月19日,沃华医药公告,公司2025年度合并报表归属于上市公司股东的净利润9571.53万元,母公司可供股东分配利润为9125.95万元。公司可供股东分配利润为8466.1万元。公司拟以2025年12月31日的总股本5.77亿股为基数,向全体股东每10股派发现金红利人民币1.46元(含税),共计派发现金红利8427.26万元(含税),不送红股,不以公积金转增股本。本利润分配预案实施后,公司2025年度累计现金分红总额为1.54亿元,占本年度归属于上市公司股东的净利润160.41%。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2025/12/30/5670204172000109704.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2025/12/30/5670204172000109704.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1768832265129251.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1768832265129251.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2604135014","title":"沃华医药最新公告:2025年净利润同比增长162.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604135014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604135014?lang=zh_cn&edition=full","pubTime":"2026-01-19 21:00","pubTimestamp":1768827614,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)公告称,公司2025年实现营业收入8.17亿元,同比增长6.96%;归属于上市公司股东的净利润为9571.53万元,同比增长162.93%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900033778.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"gpt_icon":0},{"id":"2603006445","title":"沃华医药最新公告:2025年净利同比预增119.76%-215.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603006445","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603006445?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:19","pubTimestamp":1768299599,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)发布2025年度业绩预告,预计归属于上市公司股东的净利润为8,000万元-11,500万元,比上年同期增长119.76%-215.90%。报告期内,营销改革成果日益巩固,销售队伍更加专业、成熟,已经适应沃华心可舒片进入集采后的市场竞争态势,以价换量趋势初显。医院市场得到巩固与发展,同时依托院内市场积淀的品牌与学术优势,实现向院外市场的精准延伸与高效覆盖,构建“院内+院外”全终端协同发展格局,院外市场销售初具规模。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300031645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2593905014","title":"沃华医药:不存在可能触发退市风险警示的情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593905014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593905014?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:51","pubTimestamp":1766494303,"startTime":"0","endTime":"0","summary":"证券之星消息,沃华医药(002107)12月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司有可能面值退市吗?沃华医药回复:尊敬的投资者,您好!截至目前,公司生产经营活动正常,各项业务有序开展,不存在《深圳证券交易所股票上市规则》中规定的可能触发退市风险警示或其他风险警示的情形。公司亦未收到任何关于公司股票可能面临退市风险的正式通知或相关信息。感谢您的关注!以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300037570.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0},{"id":"2588793240","title":"异动快报:沃华医药(002107)12月4日9点31分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2588793240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588793240?lang=zh_cn&edition=full","pubTime":"2025-12-04 09:36","pubTimestamp":1764812202,"startTime":"0","endTime":"0","summary":"证券之星12月4日盘中消息,9点31分沃华医药(002107)触及涨停板。其所属行业中药目前上涨。领涨股为*ST长药。该股为阿尔茨海默病,医药,中药概念热股,当日阿尔茨海默病概念上涨0.14%。12月3日的资金流向数据方面,主力资金净流入372.88万元,占总成交额5.84%,游资资金净流入274.21万元,占总成交额4.29%,散户资金净流出647.08万元,占总成交额10.13%。近5日资金流向一览见下表:沃华医药主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400006518.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2586332847","title":"沃华医药(002107)披露变更会计师事务所议案获股东会通过,11月28日股价下跌1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586332847","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586332847?lang=zh_cn&edition=full","pubTime":"2025-11-28 22:41","pubTimestamp":1764340865,"startTime":"0","endTime":"0","summary":"截至2025年11月28日收盘,沃华医药报收于6.22元,较前一交易日下跌1.11%,最新总市值为35.9亿元。公司近日发布公告,北京市星河律师事务所就山东沃华医药科技股份有限公司2025年第四次临时股东会的召集召开程序、出席会议人员资格、表决程序及表决结果出具法律意见。会议于2025年11月28日召开,审议通过《关于变更会计师事务所的议案》,表决结果合法有效。出席现场会议股东4名,代表股份297,755,608股,网络投票股东200名,代表股份2,724,927股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112800041043.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0},{"id":"2583526473","title":"天价离婚撕开A股公司治理隐忧:沃华医药“无主”之后路在何方?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583526473","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583526473?lang=zh_cn&edition=full","pubTime":"2025-11-14 13:35","pubTimestamp":1763098500,"startTime":"0","endTime":"0","summary":"一场持续15年的离婚纠纷,终于在2025年末迎来终审判决——沃华医药(维权)实际控制人赵丙贤与其前妻陆娟,将共同持有中证万融投资集团各50%的股权。这一判决,不仅让赵丙贤失去对公司的实际控制权,更将沃华医药推向了“无实际控制人”的治理真空。 随着A股“天价离婚”连续剧频频上演,从金丹科技、丽人丽妆到可靠股份,上市公司控制权因婚姻解体而剧烈动荡的案例层出不穷。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2025-11-14/doc-infxiwez1738373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","159982","002107","399300"],"gpt_icon":0},{"id":"2582377764","title":"沃华医药(002107)披露召开2025年第四次临时股东会通知,11月12日股价上涨0.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582377764","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582377764?lang=zh_cn&edition=full","pubTime":"2025-11-12 22:38","pubTimestamp":1762958292,"startTime":"0","endTime":"0","summary":"截至2025年11月12日收盘,沃华医药报收于6.41元,较前一交易日上涨0.94%,最新总市值为37亿元。该股当日开盘6.35元,最高6.42元,最低6.33元,成交额达5713.96万元,换手率为1.57%。近日,沃华医药发布公告称,公司将于2025年11月28日召开2025年第四次临时股东会,会议由董事会召集,现场会议时间为当日14:00,网络投票时间为9:15至15:00。股权登记日为2025年11月21日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200041546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0},{"id":"2580902753","title":"沃华医药(002107)披露公司实际控制人变动,11月04日股价下跌0.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580902753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580902753?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:45","pubTimestamp":1762267558,"startTime":"0","endTime":"0","summary":"近日,山东沃华医药科技股份有限公司发布公告称,北京市第三中级人民法院对赵丙贤与陆娟离婚后财产纠纷案作出二审判决,维持一审判决结果,双方平均分割北京中证万融投资集团有限公司股权,各持有50%股权。该判决仅涉及中证万融投资集团股权分割,不涉及其持有公司50.27%股份,中证万融投资集团仍为公司控股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039805.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0},{"id":"2580285732","title":"判了!离婚财产分割,沃华医药变更为无实控人!","url":"https://stock-news.laohu8.com/highlight/detail?id=2580285732","media":"e公司","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580285732?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:17","pubTimestamp":1762262220,"startTime":"0","endTime":"0","summary":"离婚财产分割,这家A股公司变更为无实控人! 目前,中证万融投资集团持有沃华医药50.27%的股份,其控股股东地位不变。赵丙贤原持有中证万融投资集团80%的股权,是沃华医药的实际控制人。 二审判决作出后即时生效,赵丙贤、陆娟所持沃华医药控股股东的股权比例相同,任何一方均无法单独控制中证万融投资集团,进而间接控制沃华医药。因此,二审判决将导致沃华医药实际控制人变动,上市公司的实际控制人由赵丙贤变为无实际控制人。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/s/2025-11-04/doc-infwhekh9760744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2580782331","title":"沃华医药(002107.SZ)将变为无实控人状态","url":"https://stock-news.laohu8.com/highlight/detail?id=2580782331","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580782331?lang=zh_cn&edition=full","pubTime":"2025-11-04 18:48","pubTimestamp":1762253324,"startTime":"0","endTime":"0","summary":"智通财经APP讯,沃华医药(002107.SZ)公告,北京市第三中级人民法院对赵丙贤先生和陆娟女士离婚后财产纠纷案作出二审判决,就双方所持公司控股股东北京中证万融投资集团有限公司(简称中证万融投资集团)的股权的分割事宜,维持北京市通州区人民法院的一审裁判,即双方平均分割中证万融投资集团的股权。判决仅涉及赵丙贤、陆娟所持中证万融投资集团股权的分割,不涉及中证万融投资集团持有公司50.27%的股份,中证万融投资集团仍为公司的控股股东;但判决结果导致赵丙贤先生、陆娟女士各持有中证万融投资集团50%的股权,引发公司实际控制人变动,公司实际控制人由赵丙贤先生变为无实际控制人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2576042975","title":"沃华医药(002107)2025年三季报简析:营收净利润同比双双增长,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2576042975","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576042975?lang=zh_cn&edition=full","pubTime":"2025-10-19 06:02","pubTimestamp":1760824940,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期沃华医药发布2025年三季报。截至本报告期末,公司营业总收入6.25亿元,同比上升8.31%,归母净利润6399.5万元,同比上升179.34%。按单季度数据看,第三季度营业总收入1.99亿元,同比上升9.77%,第三季度归母净利润1931.86万元,同比上升63.33%。本报告期沃华医药盈利能力上升,毛利率同比增幅3.95%,净利率同比增幅170.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900001301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"gpt_icon":0},{"id":"2576311460","title":"沃华医药最新公告:前三季度净利润同比增长179.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576311460","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576311460?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:11","pubTimestamp":1760699471,"startTime":"0","endTime":"0","summary":"沃华医药(002107.SZ)发布2025年三季报,前三季度实现营业收入6.25亿元,同比增长8.31%;实现归属于上市公司股东的净利润6399万元,同比增长179.34%。第三季度营业收入1.99亿元,同比增长9.77%,净利润1931.86万元,同比增长63.33%。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700032277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107"],"gpt_icon":0},{"id":"2565368494","title":"沃华医药:9月5日高管张戈减持股份合计251.46万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565368494","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565368494?lang=zh_cn&edition=full","pubTime":"2025-09-08 21:02","pubTimestamp":1757336526,"startTime":"0","endTime":"0","summary":"证券之星消息,根据9月8日市场公开信息、上市公司公告及交易所披露数据整理,沃华医药(002107)最新董监高及相关人员股份变动情况:2025年9月5日公司董秘,董事张戈共减持公司股份251.46万股,占公司总股本为0.4356%。变动期间公司股价下跌0.75%,9月5日当日收盘报6.58元。沃华医药近半年内的董监高及核心技术人员增减持详情如下:沃华医药的高管列表及最新持股情况如下:该股最近90天内无机构评级。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800031618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2510372698","title":"沃华医药最新公告:选举印文军为公司监事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2510372698","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510372698?lang=zh_cn&edition=full","pubTime":"2025-02-10 18:49","pubTimestamp":1739184578,"startTime":"0","endTime":"0","summary":"沃华医药公告称,公司于2025年2月10日召开第八届监事会第一次会议,选举印文军为公司监事长,任期同第八届监事会。会议应出席监事5名,实际出席会议监事5名。本次会议符合《公司法》等相关法律法规及《公司章程》的规定。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000026312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002107","BK0239"],"gpt_icon":0},{"id":"2503512955","title":"沃华医药(002107)1月14日主力资金净买入272.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503512955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503512955?lang=zh_cn&edition=full","pubTime":"2025-01-14 15:35","pubTimestamp":1736840156,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2025年1月14日收盘,沃华医药报收于4.46元,上涨1.83%,换手率1.31%,成交量7.49万手,成交额3296.84万元。1月14日的资金流向数据方面,主力资金净流入272.27万元,占总成交额8.26%,游资资金净流入438.62万元,占总成交额13.3%,散户资金净流出710.88万元,占总成交额21.56%。沃华医药主营业务:纯天然植物类心脑血管中成药的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025011400021235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002107"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1772742158362,"stockEarnings":[{"period":"1week","weight":-0.0438},{"period":"1month","weight":-0.053},{"period":"3month","weight":0.0083},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.5574},{"period":"ytd","weight":0.1004}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":0.01},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.0777},{"period":"1year","weight":0.2294},{"period":"ytd","weight":0.0352}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东沃华医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"40066人(较上一季度减少2.29%)","perCapita":"14261股","listingDate":"2007-01-24","address":"山东省潍坊市奎文区高新技术产业开发区梨园街3517号","registeredCapital":"57720万元","survey":" 山东沃华医药科技股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是心脑血管系统类药物、风湿骨病/跌打损伤类药物、肝胆/结石类药物、感冒发热类药物、止咳平喘类药物、胃肠疾病类药物、补益类药物、妇科药物、抗感染类药物、清热解毒/泻火通便类药物、五官科药物、皮肤科药物、维生素/矿物质/营养补充类药物、阿尔兹海默症药物、其他专科/辅助用药类药物。曾荣获国家中药标准化项目、国家重大新药创制、中华民族医药学会科学技术奖一等奖,863计划、国家重大新药创制专项、国家科学技术进步二等奖、山东省科技重大专项、山东省科技技术进步二等奖、中国制药品牌榜新锐品牌、百姓放心药等。","listedPrice":10.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沃华医药(002107)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沃华医药(002107)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沃华医药,002107,沃华医药股票,沃华医药股票老虎,沃华医药股票老虎国际,沃华医药行情,沃华医药股票行情,沃华医药股价,沃华医药股市,沃华医药股票价格,沃华医药股票交易,沃华医药股票购买,沃华医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沃华医药(002107)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沃华医药(002107)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}